Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells

Statins have been shown to improve survival of metastatic prostate cancer (mPCa). Nevertheless, their therapeutic use is still under debate. In the present study, we investigated the short-term effects of three different statins (simvastatin, atorvastatin and rosuvastatin) in various PCa cell lines...

Descripción completa

Detalles Bibliográficos
Autores principales: Kafka, Mona, Gruber, Rebecca, Neuwirt, Hannes, Ladurner, Michael, Eder, Iris E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855777/
https://www.ncbi.nlm.nih.gov/pubmed/36672537
http://dx.doi.org/10.3390/biomedicines11010029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855777/
https://www.ncbi.nlm.nih.gov/pubmed/36672537
http://dx.doi.org/10.3390/biomedicines11010029

Ejemplares similares